跳至主要内容
临床试验/ACTRN12612001002875
ACTRN12612001002875已完成3 期

Efficacy of prothrombin complex in achieving haemostasis compared to standard treatment in adult patients undergoing peritoneal cytoreductive surgery requiring massive transfusion.

St George Hospital0 个研究点目标入组 80 人开始时间: 2012年9月18日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age greater than or equal to 18 years
  • 2.Planned for peritonectomy
  • 3.Informed consent

排除标准

  • 1.Known bleeding disorder
  • 2.Known requirement for anti-coagulation e.g. prior DVT/PE requiring anti-coagulation, requirement for caval filter
  • 3.Known hypersensitivity to any pooled-blood or recombinant blood products
  • 4.Known hypersensitivity to any constituents in Prothrombinex-VF, including know allergy to heparin or a history of heparin-induced thrombocytopenia
  • 5. Evidence of active thrombosis or disseminated intravascular coagulation (DIC)

研究者

相似试验